Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 208

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis

Open access
Foley, Louise, Larkin, James, Lombard-Vance, Richard, Murphy, Andrew W, Hynes, Lisa, Galvin, Emer, Molloy, Gerard J · 2021 · BMJ Open

Abstract

Objectives: This systematic review aimed to describe medication non-adherence among people living with multimorbidity according to the current literature, and synthesise predictors of non-adherence in this population. Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses. PubMed, EMBASE, CINAHL and PsycINFO were searched for relevant articles published in English language between January 2009 and April 2019. Quantitative studies reporting medication non-adherence and/or predictors of non-adherence among people with two or more chronic conditions were included in the review. A meta-analysis was conducted with a subgroup of studies that used an inclusive definition of multimorbidity to recruit participants, rather than seeking people with specific conditions. Remaining studies reporting prevalence and predictors of non-adherence were narratively synthesised. Results: The database search produced 10 998 records and a further 75 were identified through other sources. Following full-text screening, 178 studies were included in the review. The range of reported non-adherence differed by measurement method, at 76.5% for self-report, 69.4% for pharmacy data, and 44.1% for electronic monitoring. A meta-analysis was conducted with eight studies ( n =8949) that used an inclusive definition of multimorbidity to recruit participants. The pooled prevalence of non-adherence was 42.6% (95% CI: 34.0 - 51.3%, k =8, I 2 =97%, p <0.01). The overall range of non-adherence was 7.0%–83.5%. Frequently reported correlates of non-adherence included previous non-adherence and treatment-related beliefs. Conclusions: The review identified a heterogeneous literature in terms of conditions studied, and definitions and measures of non-adherence used. Results suggest that future attempts to improve adherence among people with multimorbidity should determine for which conditions individuals require most support. The variable levels of medication non-adherence highlight the need for more attention to be paid by healthcare providers to the impact of multimorbidity on chronic disease self-management. PROSPERO registration number: CRD42019133849.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2020-044987

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 197

  1. 10.1093/pubmed/fdq057 · DOI
  2. 10.1001/jama.2012.5265 · DOI · Paper page
  3. 10.1093/fampra/cmr013 · DOI · Paper page
  4. 10.1370/afm.4 · DOI · Paper page
  5. 10.1007/s00228-013-1639-9 · DOI · Paper page
  6. Zelko, 2016, Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies, Mater Sociomed, 28, 129, 10.5455/msm.2016.28.129-132 · DOI
  7. Inauen, 2017, Assessing adherence to multiple medications and in daily life among patients with multimorbidity, Psychol Health, 32, 1233, 10.1080/08870446.2016.1275632 · DOI
  8. 10.1111/j.1365-2648.2008.04656.x · DOI · Paper page
  9. 10.1371/journal.pmed.1000097 · DOI · Paper page
  10. Foley, 2019, Prevalence and predictors of medication non-adherence among patients with multimorbidity: a systematic review protocol, HRB Open Res, 2, 10.12688/hrbopenres.12961.1 · DOI
  11. Xu, 2017, Mapping the global research landscape and knowledge gaps on multimorbidity: a bibliometric study, J Glob Health, 7, 10.7189/jogh.07.010414 · DOI
  12. Veritas Health Innovation . Covidence systematic review software. Melbourne, Australia; 2020.
  13. 10.1016/j.semarthrit.2012.12.001 · DOI · Paper page
  14. 10.18637/jss.v036.i11 · DOI · Paper page
  15. 10.1002/sim.1186 · DOI · Paper page
  16. Gaudiano, 2017, Valued living and its relationship to medication adherence in patients with bipolar and comorbid substance use disorders, J Nerv Ment Dis, 205, 178, 10.1097/NMD.0000000000000533 · DOI
  17. 10.1097/MJT.0b013e31816b69bc · DOI
  18. Albrecht, 2017, Adherence and healthcare utilization among older adults with COPD and depression, Respir Med, 129, 53, 10.1016/j.rmed.2017.06.002 · DOI
  19. Albrecht, 2016, Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease. The role of depression, Ann Am Thorac Soc, 13, 1497, 10.1513/AnnalsATS.201602-136OC · DOI
  20. 10.1097/MLR.0b013e31829fa8ed · DOI
  21. 10.1089/apc.2008.0181 · DOI
  22. 10.1007/s10461-008-9441-x · DOI
  23. Axon, 2016, Comorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes, Medicine, 95, 10.1097/MD.0000000000003983 · DOI
  24. Baca-Garcia, 2009, Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement, J Affect Disord, 115, 262, 10.1016/j.jad.2008.09.012 · DOI
  25. Badiee, 2012, Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder, AIDS Patient Care STDS, 26, 388, 10.1089/apc.2011.0447 · DOI
  26. Baik, 2012, The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure, J Ment Health Policy Econ, 15, 105
  27. Banegas, 2018, Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer, J Cancer Surviv, 12, 794, 10.1007/s11764-018-0716-6 · DOI
  28. Batchelder, 2014, Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes, J Behav Med, 37, 266, 10.1007/s10865-012-9486-1 · DOI
  29. 10.1007/s11606-013-2402-8 · DOI
  30. 10.1097/MLR.0000000000000292 · DOI
  31. 10.2146/ajhp080238 · DOI
  32. Berg, 2018, Mental health is a risk factor for poor outcomes in cardiac patients: findings from the National DenHeart survey, J Psychosom Res, 112, 66, 10.1016/j.jpsychores.2018.07.002 · DOI
  33. Bifftu, 2015, Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study, BMC Res Notes, 8, 10.1186/s13104-015-1515-z · DOI
  34. 10.1007/s10461-014-0925-6 · DOI
  35. Bogner, 2013, Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes, Am J Manag Care, 19, e85
  36. Cabrera-Marroquín, 2014, Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes, Clin Exp Rheumatol, 32, 904
  37. 10.1016/j.ijcard.2016.01.069 · DOI
  38. 10.1007/s10549-013-2424-2 · DOI
  39. 10.1002/pds.3660 · DOI
  40. Calip, 2017, Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors, Breast Cancer Res Treat, 161, 161, 10.1007/s10549-016-4043-1 · DOI
  41. Cantudo-Cuenca, 2014, Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients, J Manag Care Spec Pharm, 20, 844
  42. 10.1177/0091217415621267 · DOI
  43. 10.1002/PDS.3424 · DOI
  44. 10.1177/0145721712450923 · DOI
  45. Chou, 2017, Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis, Pharmacoepidemiol Drug Saf, 26, 676, 10.1002/pds.4198 · DOI
  46. Cicolini, 2016, Self-Reported medication adherence and beliefs among elderly in multi-treatment: a cross-sectional study, Appl Nurs Res, 30, 131, 10.1016/j.apnr.2015.11.011 · DOI
  47. 10.1016/j.cct.2013.07.010 · DOI
  48. 10.1007/s11606-014-3072-x · DOI
  49. 10.1007/s12160-011-9322-9 · DOI
  50. Cziraky, 2015, Clinical outcomes and medication adherence in acute coronary syndrome patients with and without type 2 diabetes mellitus: a longitudinal analysis 2006-2011, J Manag Care Spec Pharm, 21, 470
  51. Daniali, 2018, The prevalence of depression and its association with self-management behaviors in chronic disease patients, Iran J Psychiatry, 13
  52. 10.1177/0956462414535207 · DOI
  53. Davis, 2011, Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial, Hypertension, 57, 1061, 10.1161/HYPERTENSIONAHA.111.169367 · DOI
  54. 10.3122/jabfm.2015.06.150010 · DOI
  55. Desai, 2014, Adherence to oral diabetes medications among users and nonusers of antipsychotic medication, Psychiatr Serv, 65, 215, 10.1176/appi.ps.201300118 · DOI
  56. Dhamane, 2017, Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients, Int J Chron Obstruct Pulmon Dis, 12, 115, 10.2147/COPD.S114802 · DOI
  57. Domino, 2014, Heterogeneity in the quality of care for patients with multiple chronic conditions by psychiatric comorbidity, Med Care, 52 Suppl 3, S101, 10.1097/MLR.0000000000000024 · DOI
  58. DuChane, 2014, Impact of HIV-specialized pharmacies on adherence to medications for comorbid conditions, J Am Pharm Assoc, 54, 493, 10.1331/JAPhA.2014.13165 · DOI
  59. Eton, 2017, Healthcare provider relational quality is associated with better self-management and less treatment burden in people with multiple chronic conditions, Patient Prefer Adherence, 11, 1635, 10.2147/PPA.S145942 · DOI
  60. Farley, 2012, Antipsychotic adherence and its correlation to health outcomes for chronic comorbid conditions, Prim Care Companion CNS Disord, 14, m01324
  61. Ferguson, 2017, Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. outcomes of the AFASTER study, Eur J Cardiovasc Nurs, 16, 113, 10.1177/1474515116642604 · DOI
  62. Foguet-Boreu, 2017, Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of "real world" data, Prim Care Diabetes, 11, 348, 10.1016/j.pcd.2017.03.007 · DOI
  63. Gathright, 2017, The impact of medication nonadherence on the relationship between mortality risk and depression in heart failure, Health Psychol, 36, 839, 10.1037/hea0000529 · DOI
  64. Gaynes, 2015, Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential, Gen Hosp Psychiatry, 37, 277, 10.1016/j.genhosppsych.2015.03.021 · DOI
  65. Gentil, 2019, Adherence to oral antihyperglycemic agents among older adults with mental disorders and its effect on health care costs, Quebec, Canada, 2005–2008, Prev Chronic Dis, 12
  66. Gibson, 2018, Patient expectations of hypertension and diabetes medication: excessive focus on short-term benefits, SAGE Open Med, 6, 1, 10.1177/2050312118821119 · DOI
  67. Gnanasan, 2011, Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care, Int J Clin Pharm, 33, 44, 10.1007/s11096-010-9452-3 · DOI
  68. 10.1007/s12160-011-9268-y · DOI
  69. Grove, 2017, Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia, Gen Hosp Psychiatry, 47, 14, 10.1016/j.genhosppsych.2017.03.002 · DOI
  70. Gundling, 2013, Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus, Digestion, 87, 75, 10.1159/000343458 · DOI
  71. Gupte-Singh, 2015, Impact of comorbid depression on medication adherence and asthma-related healthcare costs in Texas Medicaid patients with asthma, J Pharm Health Serv Res, 6, 197, 10.1111/jphs.12111 · DOI
  72. 10.1503/cmaj.131807 · DOI
  73. 10.1331/JAPhA.2009.08184 · DOI
  74. Hansen, 2012, Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs, Psychiatr Serv, 63, 920, 10.1176/appi.ps.201100328 · DOI
  75. 10.1177/1060028014563266 · DOI
  76. Hansen, 2018, Continuity of medication management among adults with schizophrenia and comorbid cardiometabolic conditions, J Pharm Health Serv Res, 9, 13, 10.1111/jphs.12201 · DOI
  77. Hapangama, 2013, Substance use disorders among mentally ill patients in a General Hospital in Sri Lanka: prevalence and correlates, Ceylon Med J, 58, 111, 10.4038/cmj.v58i3.6103 · DOI
  78. Hawke, 2013, Bipolar disorder with comorbid anxiety disorders: impact of comorbidity on treatment outcome in cognitive-behavioral therapy and psychoeducation, Int J Bipolar Disord, 1, 10.1186/2194-7511-1-15 · DOI
  79. 10.2165/11530680-000000000-00000 · DOI
  80. Ihle, 2017, Prospective and retrospective memory are differentially related to self-rated omission and commission errors in medication adherence in multimorbidity, Appl Neuropsychol Adult, 24, 505, 10.1080/23279095.2016.1209675 · DOI
  81. Iyengar, 2016, Medication nonadherence among Medicare beneficiaries with comorbid chronic conditions: influence of pharmacy dispensing channel, J Manag Care Spec Pharm, 22, 550
  82. James, 2018, Exploratory study of impact of cancer-related posttraumatic stress symptoms on diabetes self-management among cancer survivors, Psychooncology, 27, 648, 10.1002/pon.4568 · DOI
  83. Jaworski, 2011, Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia, Psychiatry Res, 185, 129, 10.1016/j.psychres.2010.06.005 · DOI
  84. Jing, 2011, Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members, J Manag Care Pharm, 17, 355
  85. Joseph, 2017, A study on prescription pattern of antihypertensive agents in chronic renal failure patients and assessment of medication adherence, Int J Pharm Sci Rev Res, 45, 72
  86. 10.1097/QAI.0b013e3181b720e7 · DOI
  87. Kalichman, 2015, Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework, J Behav Med, 38, 632, 10.1007/s10865-015-9633-6 · DOI
  88. Kamal, 2018, HIV-Infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy, HIV Med, 19, 49, 10.1111/hiv.12542 · DOI
  89. Katerndahl, 2012, Effect of comorbid depression on outcomes in diabetes and its relationship to quality of care and patient adherence: a statewide primary care ambulatory research and resources consortium study, Prim Care Companion CNS Disord, 14
  90. 10.1097/PSY.0b013e3181bd8f55 · DOI
  91. 10.4103/1947-2714.93376 · DOI
  92. Kenning, 2013, Primary care practitioner and patient understanding of the concepts of multimorbidity and self-management: a qualitative study, SAGE Open Med, 1, 205031211351000, 10.1177/2050312113510001 · DOI
  93. 10.1097/PSY.0b013e3181c4e3e9 · DOI
  94. Kong, 2012, Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection, J Gen Intern Med, 27, 1159, 10.1007/s11606-012-2043-3 · DOI
  95. Kostev, 2018, Association between depression and persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients in Germany, Psychiatry Res, 261, 90, 10.1016/j.psychres.2017.12.058 · DOI
  96. 10.1093/schbul/sbn106 · DOI
  97. 10.1016/j.psychres.2011.03.013 · DOI
  98. 10.1192/bjp.bp.114.155820 · DOI
  99. Krivoy, 2017, Low adherence to antidepressants is associated with increased mortality following stroke: a large nationally representative cohort study, Eur Neuropsychopharmacol, 27, 970, 10.1016/j.euroneuro.2017.08.428 · DOI
  100. 10.1007/s12160-010-9217-1 · DOI
  101. Krumme, 2018, Medication synchronization programs improve adherence to cardiovascular medications and health care use, Health Aff, 37, 125, 10.1377/hlthaff.2017.0881 · DOI
  102. 10.1007/s11126-009-9100-z · DOI
  103. Langness, 2014, Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy, J Manag Care Spec Pharm, 20, 809
  104. 10.1007/s10488-010-0320-1 · DOI
  105. Li, 2016, Medication adherence and blood pressure control among hypertensive patients with coexisting long-term conditions in primary care settings: a cross-sectional analysis, Medicine, 95, 10.1097/MD.0000000000003572 · DOI
  106. 10.1370/afm.1343 · DOI · Paper page
  107. Lo Re, 2013, Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients, AIDS Behav, 17, 94, 10.1007/s10461-012-0288-9 · DOI
  108. 10.2337/dc13-0051 · DOI
  109. 10.1016/J.JDIACOMP.2017.02.016 · DOI
  110. 10.1177/1078390310395586 · DOI
  111. Mathew, 2013, Assessment of medication adherence in type-2 diabetes patients on poly pharmacy and the effect of patient counseling given to them in a Multispecialty Hospital, J Basic Clin Pharm, 5, 15, 10.4103/0976-0105.128251 · DOI
  112. 10.1016/j.jpsychores.2010.01.026 · DOI
  113. 10.1177/1090198116637601 · DOI
  114. 10.1080/09540120802001705 · DOI
  115. 10.2196/jmir.3269 · DOI · Paper page
  116. Monroe, 2018, Randomized controlled trial of a pictorial aid intervention for medication adherence among HIV-positive patients with comorbid diabetes or hypertension, AIDS Care, 30, 199, 10.1080/09540121.2017.1360993 · DOI
  117. 10.1007/s10461-011-0072-2 · DOI
  118. 10.1080/09540121.2012.672718 · DOI
  119. 10.1007/s10461-014-0971-0 · DOI
  120. 10.1053/j.ajkd.2010.02.348 · DOI
  121. 10.1136/bmjopen-2016-011613 · DOI
  122. 10.1136/bmjopen-2017-017740 · DOI
  123. Naidoo, 2013, Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study, BMC Public Health, 13, 10.1186/1471-2458-13-396 · DOI
  124. Nakimuli-Mpungu, 2019, Recruitment and baseline characteristics of participants in the social, emotional, and economic empowerment through knowledge of group support psychotherapy study (SEEK-GSP): cluster randomized controlled trial, JMIR Res Protoc, 8, 10.2196/11560 · DOI
  125. Natarajan, 2013, Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension, Can Fam Physician, 59, e93
  126. Nelson, 2011, Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders, Psychosomatics, 52, 310, 10.1016/j.psym.2011.03.004 · DOI
  127. Nelson, 2011, Medication adherence and glycemic control in patients with psychotic disorders in the Veterans Affairs healthcare system, Pharm Pract, 9, 57
  128. Neugut, 2016, Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer, JAMA Oncol, 2, 1326, 10.1001/jamaoncol.2016.1291 · DOI
  129. Newville, 2015, The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance, Int J Behav Med, 22, 214, 10.1007/s12529-014-9429-z · DOI
  130. 10.1111/j.1524-4733.2008.00474.x · DOI
  131. Otenyo, 2018, Factors affecting adherence to anti-hypertensive medication regimen among hemodialysis patients attending a private hospital Mombasa, Kenya, Int J Pharm Sci Res, 9, 755
  132. Owen-Smith, 2016, Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness, Gen Hosp Psychiatry, 38, 9, 10.1016/j.genhosppsych.2015.07.010 · DOI
  133. Padman, 2017, A study on prescription pattern of oral hypoglycemic agents and insulin therapy in chronic renal failure patients and assessment of medication adherence, Int J Pharm Sci Rev Res, 45, 68
  134. Pantalone, 2012, Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men, J Behav Med, 35, 520, 10.1007/s10865-011-9381-1 · DOI
  135. Parpouchi, 2017, Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness, Addict Behav Rep, 6, 106
  136. Patel, 2016, Predictors of medication adherence and persistence in Medicaid enrollees with developmental disabilities and type 2 diabetes, Res Social Adm Pharm, 12, 592, 10.1016/j.sapharm.2015.09.008 · DOI
  137. Pence, 2015, The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial, AIDS, 29, 1975, 10.1097/QAD.0000000000000797 · DOI
  138. 10.1345/aph.1L368 · DOI
  139. Puyat, 2017, Comorbid chronic general health conditions and depression care: a population-based analysis, Psychiatr Serv, 68, 907, 10.1176/appi.ps.201600309 · DOI
  140. Qian, 2014, Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease, Int J Geriatr Psychiatry, 29, 49, 10.1002/gps.3968 · DOI
  141. Rattinger, 2012, The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure, Am J Geriatr Pharmacother, 10, 69, 10.1016/j.amjopharm.2011.11.003 · DOI
  142. Reed, 2018, A self-management support program for older Australians with multiple chronic conditions: a randomised controlled trial, Med J Aust, 208, 69, 10.5694/mja17.00127 · DOI
  143. Rosenblum, 2014, Efficacy of dual focus mutual aid for persons with mental illness and substance misuse, Drug Alcohol Depend, 135, 78, 10.1016/j.drugalcdep.2013.11.012 · DOI
  144. Roux, 2012, Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users, Addiction, 107, 152, 10.1111/j.1360-0443.2011.03608.x · DOI
  145. Saadat, 2015, Adherence to antihypertensives in patients with comorbid condition, Nephrourol Mon, 7, 10.5812/numonthly.29863 · DOI
  146. 10.1037/a0012715 · DOI · Paper page
  147. 10.1037/a0028208 · DOI · Paper page
  148. 10.2337/dc13-0816 · DOI · Paper page
  149. Santorelli, 2016, Effects of breast cancer on chronic disease medication adherence among older women, Pharmacoepidemiol Drug Saf, 25, 898, 10.1002/pds.3971 · DOI
  150. 10.1159/000321688 · DOI
  151. Schüz, 2011, Changes in functional health, changes in medication beliefs, and medication adherence, Health Psychol, 30, 31, 10.1037/a0021881 · DOI
  152. 10.1016/j.jpsychores.2010.07.014 · DOI
  153. Schüz, 2014, Multiple illness perceptions in older adults: effects on physical functioning and medication adherence, Psychol Health, 29, 442, 10.1080/08870446.2013.863884 · DOI
  154. Shi, 2010, Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome, Curr Med Res Opin, 26, 2499, 10.1185/03007995.2010.519278 · DOI
  155. 10.1007/s00520-009-0802-4 · DOI
  156. Shoval, 2017, Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients, Parkinsonism Relat Disord, 43, 92, 10.1016/j.parkreldis.2017.07.032 · DOI
  157. 10.1371/journal.pone.0053022 · DOI
  158. Slabbert, 2015, The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: a prospective study in a South African private healthcare cohort, AIDS Res Ther, 12, 10.1186/s12981-015-0050-2 · DOI
  159. Soto, 2015, Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean Hospital, Int J Clin Pharm, 37, 734, 10.1007/s11096-015-0131-2 · DOI
  160. 10.1177/1474651409357034 · DOI
  161. 10.1200/JOP.2014.003046 · DOI
  162. Taira, 2017, Examining factors associated with nonadherence and identifying providers caring for nonadherent subgroups, J Pharm Health Serv Res, 8, 247, 10.1111/jphs.12193 · DOI
  163. 10.1177/1054773813481801 · DOI
  164. 10.1093/arclin/acu092 · DOI
  165. 10.1016/j.dhjo.2013.02.003 · doi:10.1016/j.dhjo.2013.02.003
  166. Vatcharavongvan, 2017, Polypharmacy, medication adherence and medication management at home in elderly patients with multiple non-communicable diseases in Thai primary care, Fam Med Prim Care Rev, 19, 412, 10.5114/fmpcr.2017.70818 · DOI
  167. Vega, 2017, Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder, Curr Med Res Opin, 33, 1879, 10.1080/03007995.2017.1347092 · DOI
  168. Villar, 2009, Medication adherence and persistence in severe obstructive sleep apnea, Sleep, 32, 623, 10.1093/sleep/32.5.623 · DOI
  169. 10.1007/s12160-011-9295-8 · DOI
  170. 10.1089/tmj.2011.0237 · DOI
  171. 10.1016/j.socscimed.2013.03.012 · DOI
  172. Wei, 2018, The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: a longitudinal cohort study, Int J Geriatr Psychiatry, 33, e212, 10.1002/gps.4772 · DOI
  173. Weiss, 2016, Illness perceptions, medication beliefs, and adherence to antiretrovirals and medications for comorbidities in adults with HIV infection and hypertension or chronic kidney disease, J Acquir Immune Defic Syndr, 73, 403, 10.1097/QAI.0000000000001075 · DOI
  174. Wenze, 2015, Adjunctive psychosocial intervention following hospital discharge for patients with bipolar disorder and comorbid substance use: a pilot randomized controlled trial, Psychiatry Res, 228, 516, 10.1016/j.psychres.2015.06.005 · DOI
  175. Wong, 2014, The association between multimorbidity and poor adherence with cardiovascular medications, Int J Cardiol, 177, 477, 10.1016/j.ijcard.2014.09.103 · DOI
  176. 10.1177/0956462414535206 · DOI
  177. C-H, 2010, The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder, Res Social Adm Pharm, 8, 193
  178. 10.1345/aph.1P539 · DOI
  179. 10.1016/j.cardfail.2013.03.010 · DOI
  180. 10.1007/s10549-018-4890-z · DOI
  181. Xia, 2015, Impact of mood disorder on medication adherence in patients with chronic diseases at a Shanghai rural hospital, Int J Pharmacol, 11, 518, 10.3923/ijp.2015.518.522 · DOI
  182. Xue, 2019, Treatment adherence as a mediator of blood pressure control in Chinese older adults with depression, Int J Geriatr Psychiatry, 34, 432, 10.1002/gps.5032 · DOI
  183. Yang, 2010, Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs, J Am Pharm Assoc, 50, 527, 10.1331/JAPhA.2010.09071 · DOI
  184. 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  185. 10.1080/08870446.2012.662973 · DOI
  186. 10.1016/j.ijnurstu.2014.10.010 · DOI · Paper page
  187. Pednekar, 2019, Methods for measuring multiple medication adherence: a systematic Review-Report of the ISPOR medication adherence and persistence special interest group, Value Health, 22, 139, 10.1016/j.jval.2018.08.006 · DOI
  188. 10.1176/appi.ps.58.2.207 · doi:10.1176/appi.ps.58.2.207
  189. 10.4088/JCP.8001tx17c · DOI
  190. 10.1186/s12877-019-1031-4 · DOI
  191. Dezii, 2002, Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes, South Med J, 95, 68, 10.1097/00007611-200295010-00014 · DOI
  192. 10.1038/s41598-018-23276-8 · DOI · Paper page
  193. Khan, 2018, Challenges and innovations of drug delivery in older age, Adv Drug Deliv Rev, 135, 3, 10.1016/j.addr.2018.09.003 · DOI
  194. 10.1007/s40266-014-0153-9 · DOI
  195. 10.1016/j.cger.2012.01.008 · DOI · Paper page
  196. Lam, 2015, Medication adherence measures: an overview, Biomed Res Int, 2015, 1
  197. 10.2165/00002512-200421120-00004 · DOI · Paper page

Cited by

See all 208

Metadata

Authors
Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J.
Venue
BMJ Open
Publisher
BMJ
Published
2021-09
Volume
11
Issue
9
Pages
e044987
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3197047107
Cited by
208
References
16
FWCI
8.66
Type
journal article
Language
en
Open access
gold
Funders
Health Research Board (CDA-2018-003)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2020-044987
The paper
Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J. (2021). Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2020-044987

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.